Clinical Trial Update: Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating thalidomide for ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED